Quarterly Statement Of Cash Flows

MEDIKIT CO.,LTD - Filing #7299414

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
2,280,151,000 JPY
2,397,927,000 JPY
Depreciation
664,143,000 JPY
622,933,000 JPY
Impairment losses
55,000 JPY
55,000 JPY
Increase (decrease) in allowance for doubtful accounts
-5,000 JPY
-43,000 JPY
Interest and dividend income
-12,081,000 JPY
-10,137,000 JPY
Interest expenses
3,778,000 JPY
3,795,000 JPY
Decrease (increase) in trade receivables
299,387,000 JPY
424,424,000 JPY
Decrease (increase) in inventories
29,635,000 JPY
-143,687,000 JPY
Increase (decrease) in trade payables
-144,665,000 JPY
-58,585,000 JPY
Other, net
-848,910,000 JPY
58,323,000 JPY
Subtotal
2,262,250,000 JPY
3,345,348,000 JPY
Interest and dividends received
11,488,000 JPY
10,136,000 JPY
Interest paid
-7,465,000 JPY
-7,461,000 JPY
Income taxes paid
-857,416,000 JPY
-983,981,000 JPY
Net cash provided by (used in) operating activities
1,408,858,000 JPY
2,442,514,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,654,197,000 JPY
-552,406,000 JPY
Proceeds from sale of property, plant and equipment
1,080,000 JPY
JPY
Purchase of investment securities
-500,000 JPY
JPY
Net cash provided by (used in) investing activities
-1,660,188,000 JPY
-500,135,000 JPY
Cash flows from financing activities
Dividends paid
-681,569,000 JPY
-1,179,962,000 JPY
Net cash provided by (used in) financing activities
-681,569,000 JPY
-1,179,962,000 JPY
Effect of exchange rate change on cash and cash equivalents
97,119,000 JPY
89,692,000 JPY
Net increase (decrease) in cash and cash equivalents
-835,780,000 JPY
852,109,000 JPY
Cash and cash equivalents
18,342,926,000 JPY
19,111,087,000 JPY
18,445,058,000 JPY
17,592,949,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.